Rimas Orentas

10PUBLICATIONS
133CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Health equityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Sep 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|May 08, 2024
Nothing about us without us: Advocacy and engagement in genetic medicine.

Olabimpe Olayiwola, Adam Castillejo, Michael Louella

|Mar 05, 2024
Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Samuel A Ritmeester-Loy, Isabella H Draper, Eric C Bueter

|Jan 06, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.

Katherine E Masih, Rebecca A Gardner, Hsien-Chao Chou

|Oct 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

Pageof 2

Frequent Collaborators

4 joint publications

Dimiter S Dimitrov

4 joint publications

Ashley L Wilson

3 joint publications

Joshua A Gustafson

3 joint publications

Michael C Jensen